Loading...
XTAE
EMITF
Market cap568kUSD
Jul 10, Last price  
749.50ILS
Name

Elbit Imaging Ltd

Chart & Performance

D1W1MN
XTAE:EMITF chart
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
3.00%
Rev. gr., 5y
-30.45%
Revenues
0k
-100.00%
816,224,0001,665,605,6503,507,465,6421,098,317,000693,377,0001,473,712,0001,011,298,000671,086,000360,597,000398,578,000347,964,000261,858,000782,829,00000000328,0000
Net income
-5m
L-70.64%
86,884,800559,483,187921,946,379-103,714,000-533,269,00061,998,000-264,919,000-293,590,000-1,155,645,0001,008,999,000-186,150,000-194,830,000-338,034,000-517,833,000-107,497,000229,851,000-20,498,000-311,000-18,143,000-5,327,000
CFO
-582k
L-80.29%
-99,042,600-521,802,3750220,656,000-754,331,000-334,587,000-240,889,000-148,624,000-16,873,000281,135,000191,353,000158,755,000433,812,000-20,293,000-14,803,000-15,649,000-3,378,000-3,437,000-2,953,000-582,000
Dividend
Jun 29, 20230.58332 ILS/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Elbit Imaging Ltd., together with its subsidiaries, develops, produces, and markets therapeutic medical systems for performing non-invasive treatments on the human body in Israel and internationally. The company offers treatment-oriented medical systems with ultrasound beam and magnetic resonance imaging for noninvasive treatments in human body. It also offers medical products based on stem cells derived primarily from umbilical cord blood and intended for bone marrow transplantation in patients with leukemia or lymph node cancer, non-malignant blood diseases, and metabolic genetic diseases. In addition, the company is involved in the sale of plots and villas in India. The company was formerly known as Elbit Medical Imaging Ltd. and changed its name to Elbit Imaging Ltd. in November 2007. Elbit Imaging Ltd. was incorporated in 1996 and is headquartered in Petach Tikva, Israel.
URL
http://www.elbitimaging.com
IPO date
Nov 01, 1996
Employees
3
Domiciled in
IL
Incorporated in
IL

Valuation

Title
ILS in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT